2025 Annual Report on the Storage, Management, and Use of Raised Funds
The company and its board of directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, with no false records, misleading statements, or material omissions.
In accordance with the "Supervision Measures for the Management of Raised Funds by Listed Companies" issued by the China Securities Regulatory Commission, the "Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 2 - Norms for the Operation of GEM Listed Companies (2025 Revision)," and the "Announcement Format Guidelines for GEM Listed Companies on the Shenzhen Stock Exchange No. 2 - Announcement Format (2025 Revision)" issued by the Shenzhen Stock Exchange, this report details the company's storage, management, and use of raised funds for 2025.
I. Basic情况 of Raised Funds
(I) Actual Amount of Raised Funds and Time of Receipt
As per the "Approval on the Registration of the Private Placement of Shares by Ruipute Biotechnology Co., Ltd." (Securities Regulatory Permit (2021) No. 2974) issued by the China Securities Regulatory Commission on September 10, 2021, the company was approved to issue 63,984,674 ordinary shares (A shares) to specific objects at an issue price of RMB 20.88 per share. The total raised funds amounted to RMB 1,335,999,993.12. After deducting issuance expenses (excluding tax) of RMB 13,979,522.73, the net amount of raised funds is RMB 1,322,020,470.39.
These raised funds were received on October 27, 2021. Lixin Certified Public Accountants (Special General Partnership) audited the receipt of funds from the company's private placement of shares and issued the "Capital Verification Report" (Xin Shi Shi Bao Zi [2021] No. ZG11889).
(II) Amount Used and Current Balance for the Year
The amount of raised funds used during the year was RMB 49,827,954.58. As of December 31, 2025, the company has cumulatively used RMB 840,485,793.39 of raised funds, with a remaining balance of RMB 515,816,377.79. The details are as follows:
| Item | Amount (RMB) |
|---|---|
| Net raised funds | 1,322,020,470.39 |
| Less: Cumulative project expenses | 840,327,863.73 |
| Item | Amount (RMB) |
|---|---|
| Add: Interest income | 51,772,817.52 |
| Less: Surplus funds from investment projects used for working capital | 17,482,736.50 |
| Less: Other expenses | 157,929.66 |
| Less: Handling fees | 8,380.23 |
| Balance of raised funds | 515,816,377.79 |
II. Storage and Management of Raised Funds
(I) Management of Raised Funds
In accordance with the "Company Law," the "Securities Law," the "Shenzhen Stock Exchange GEM Stock Listing Rules (2025 Revision)," and the "Shenzhen Stock Exchange Self-Regulatory Guidelines for GEM Listed Companies No. 2 - Norms for the Operation of GEM Listed Companies (2025 Revision)," and other relevant laws and regulations, and considering the company's actual situation, the company has formulated the "Raised Funds Management System" (hereinafter referred to as the "Management System") which clearly stipulates the storage, use, and management of raised funds to ensure their standardized use.